VLA
Click for more information
0.00% $1.75 viralytics limited

Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-58

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. 3rddoor
    74 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    09/01/18
    14:21
    Post #: 30161819
    Just reading the previous two announcements, Malcolm McColl states that VLA are wanting to proceed to a pivotal phase three trial in melanoma patients, the investor presentation notes progressing MITCI into a pivotal study. Does mean the intention is to take Yervoy+Cavatak to phase 3 or am I missreading the comments?
    VLA Price at posting: 80.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.